Trials / Completed
CompletedNCT03762109
The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether administration of a non-centrally acting muscle relaxants will improve the Overall Benefit of Analgesia Score (OBAS), and Richmond Agitation Sedation Scale (RASS) scores in patients undergoing lumbar fusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dantrolene | muscle relaxant |
| DRUG | Placebo Oral Tablet | inactive pill |
Timeline
- Start date
- 2019-07-29
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2018-12-03
- Last updated
- 2024-07-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03762109. Inclusion in this directory is not an endorsement.